Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Acquisition

4 May 2022 07:00

RNS Number : 1863K
Restore PLC
04 May 2022
 

4 May 2022

 

Restore plc

("Restore" or the "Group" or "Company")

 

Strategic acquisition increases Restore Technology capability

 

 

Restore (AIM: RST), the UK's leading provider of digital and information management and secure lifecycle services, is pleased to announce that it acquired 100% of the share capital of Ultratec (Holdings) Limited ("Ultratec") on 3rd May 2022.

 

This investment represents a further milestone in the Group's strategic development of Restore Technology.

 

Ultratec is a highly regarded provider of secure data erasure and physical data destruction services, bespoke technology recycling solutions, hard drive parts supply and Data Centre focussed hardware maintenance services.

 

A key feature of the business are the innovative and proprietary software solutions, Genesis* and Nemesis*. Both these products deliver additional value by extending the life of hard drive technologies, improving re-use recovery rates and securely erasing data substantially faster than comparable software solutions. The business has around 70 staff based in two locations at Stevenage and Henlow.

 

For the year to 31st March 2022, Ultratec achieved a revenue of £7.6 million, generating a profit before tax of £1.2 million and had net assets of £1.8 million. The business is being acquired in cash for an enterprise value of £9.4 million. In addition to the additional technical capability provided by the Genesis and Nemesis technologies, the combination will further increase the scale of Restore Technology and achieve synergies across revenues and operations.

 

*Genesis was developed by Ultratec as a proprietary software and hardware appliance that securely erases data on various hard disk formats and will also reconstruct hard drives to make previously damaged hard drives useable again. The appliance includes cloud based software to ease deployment and is delivered with a subscription model with recuring revenues. Nemesis performs the same functionality as Genesis but with networking equipment which is a growing market with the increasing amounts of data on networking devices posing a security risk for organisations.

 

www.ultratec.co.uk/genesis

www.ultratestsolutions.com

 

CHARLES BLIGH, CEO, COMMENTED:

 

"I am delighted to welcome the team at Ultratec to the Group and we look forward to developing the business together as part of Restore Technology, our rapidly growing IT lifecycle services business.

 

The team at Ultratec have an excellent reputation in the sector with a specialist focus on hard drive and storage products from repair, erasure and resale. Their innovative Genesis and Nemesis technologies represent opportunities to further expand our capabilities in technology lifecycle services. I am excited about this acquisition and the opportunity it represents for our business."

 

 

For further information:

Restore plc

www.restoreplc.com

Charles Bligh, CEONeil Ritchie, CFO

+44 (0) 207 409 2420

Investec (Nominated Adviser and Joint Broker)

www.investec.com

Carlton Nelson

James Rudd

 

+44 (0) 207 597 5970

Canaccord Genuity (Joint Broker, Corporate Advisor))

www.canaccordgenuity.com

Max Hartley

Chris Robinson

 

+44 (0) 207 523 8000

Citi (Joint Broker)

www.citigroup.com

Stuart Field

Luke Spells

 

+44 (0) 207 986 4074

Buchanan Communications (PR enquiries)

www.buchanan.uk.com

Charles Ryland

Stephanie Whitmore

 

+44 (0) 207 466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSSAFMDEESEDI
Date   Source Headline
30th Jan 20207:00 amRNSFull Year 2019 Trading Update
14th Jan 20207:00 amRNSIssue of Equity
20th Dec 201910:12 amRNSIssue of Equity
13th Dec 20197:00 amRNSNon-Executive Directorate Changes
26th Nov 20191:31 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSTrading Update and Capital Markets Day
17th Oct 20195:34 pmRNSHolding(s) in Company
17th Oct 20191:14 pmRNSExercise of Options
16th Oct 20199:30 amRNSHolding(s) in Company
4th Oct 20192:25 pmRNSDirector/PDMR Shareholding
4th Oct 201910:35 amRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSExercise of Options
31st Jul 20197:00 amRNSHalf Year Results 2019
13th Jun 201910:12 amRNSExercise of Options and Directors' Dealing
21st May 201910:36 amRNSResult of AGM
21st May 20197:00 amRNSAGM Statement and Appointment of CFO
1st May 20192:43 pmRNSHolding(s) in Company
29th Apr 20195:24 pmRNS2018 Final Dividend
22nd Mar 20197:00 amRNSDirector/PDMR Shareholding
19th Mar 20191:21 pmRNSDirector/PDMR Shareholding
19th Mar 201912:51 pmRNSNotice of AGM & Annual Report
18th Mar 20197:00 amRNSDirectorate Change
18th Mar 20197:00 amRNSFull Year Unaudited Results 2018
26th Feb 20197:00 amRNSSale of ITP Group Holdings Limited
11th Feb 20197:00 amRNSChange of Adviser
6th Feb 20193:17 pmRNSHolding(s) in Company
5th Feb 201912:39 pmRNSHolding(s) in Company
4th Feb 20192:20 pmRNSDirector/PDMR Shareholding
1st Feb 20194:28 pmRNSHolding(s) in Company
1st Feb 20192:27 pmRNSHolding(s) in Company
29th Jan 20192:52 pmRNSHolding(s) in Company
21st Jan 20195:05 pmRNSHolding(s) in Company
21st Jan 20195:02 pmRNSHolding(s) in Company
21st Jan 201912:45 pmRNSDirector/PDMR Shareholding
17th Jan 20194:58 pmRNSHolding(s) in Company
17th Jan 20194:55 pmRNSHolding(s) in Company
15th Jan 20199:40 amRNSDirector/PDMR Shareholding
14th Jan 20194:41 pmRNSSecond Price Monitoring Extn
14th Jan 20194:36 pmRNSPrice Monitoring Extension
14th Jan 20197:00 amRNSYear End Trading Update
13th Dec 20187:00 amRNSDirectorate Changes
13th Nov 20187:00 amRNSInvestor Day
9th Nov 20187:00 amRNSExercise of Options
7th Nov 20182:30 pmRNSHolding(s) in Company
6th Nov 201810:01 amRNSHolding(s) in Company
29th Oct 201811:00 amRNSIssue of Equity
17th Sep 20187:00 amRNSHalf Year Results 2018
5th Sep 201812:19 pmRNSHolding(s) in Company
26th Jul 201811:27 amRNSHolding(s) in Company
23rd Jul 20187:00 amRNSHalf Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.